Could depression be a new branch of MIA syndrome?

Clinical Nephrology

Volumn 71, Issue 2, 2009, Pages 164-172

  Simic Ogrizovic, S ^a   Jovanovic, D ^a   Dopsaj, V ^b   Radovic, M ^a   Sumarac, Z ^b   Bogavac, S N ^c   Stosovic, M ^a   Stanojevic, M ^a   Nesic, V ^a  

^a Institute of Urology and Nephrology   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c School of Pharmacy   (Serbia)

Author keywords

Atherosclerosis (MIA); Depression; Dialysis mortality; Inflammation; Malnutrition

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 6; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BECK DEPRESSION INVENTORY; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; PREDICTOR VARIABLE; PREVALENCE; PROTEIN BLOOD LEVEL; TREATMENT DURATION; BLOOD; CHI SQUARE DISTRIBUTION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SYNDROME;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MALNUTRITION; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SYNDROME;

EID: 64549127855     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp71164     Document Type: Article

References (50)

1. Anisman H, Merali Z, Poulter M, Hyley S. Cytokines as a precipitant of depressive illness: Animal and human studies. Curr Pharm Res. 2005; 11: 963-972.
2. Beck A, Brown G, Steer, R. Beck Depression Inventory II manual. San Antonio: TX; The Psychological Corporation. 1996.
3. Blake P, Daugirdas P. Quantification and prescription general principles. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds). Replacement of renal function by Dialysis. Dordrecht: Kluwer Academic Publishers; 1996. p. 619-656.
4. Bland M, Altman G. Transformations, means and confidence intervals. BMJ. 1996; 312: 1079.
5. Boulware E, Liu Y, Fink N, Coresh J, Ford D, Klag M, Powe N. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol. 2006; 496-504.
6. Chen S, Wu C, Wang Y, Jaw S. Depression in chronic hemodilaysis patients. Nephrology. 2003; 8: 121-126.
7. Christensen A, Wiebe J, Smith T, Turner C. Prediction of survival among hemodialysis patients effect of perceived family support. Health Psychol. 1994; 13: 521-525.
8. Devins G, Mann J, Mandin H, Paul L, Homs R, Burgess E, Taub K, Schorr S, Leourneau P, Buckle S. Psychosocial predictors of survival in ESRD. J Nerv Ment Dis. 1990; 178: 127-133.
9. Dogan E, Erynocu B, Sayarlioglu H, Agargun M. Relation between depression, some laboratory parameters, and quality of life in hemodailysis patients. Ren Fail. 2005; 27: 695-699.
10. Eiam-Ong S, Sitprija V. Comorbidities in patients with end-stage renal disease in developing countries. Artif Organs. 2002; 26: 753-756.
11. Finkelstein F, Finkelstein S. Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant. 2000; 15: 1911-1913.
12. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month survival after myocardial infarction. Circulation. 1996; 91: 999-1005.
13. Headayati S, Boswort H, Kuchibhatla M. Kimmel PL, Szczech LA et al. The predictive value of self-reported scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006; 69: 1662-1668.
14. Hedayati S, Grambow S, Szczech L, Stechuchak K, Allen A. Bosworth H. Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodyalisis. Am J Kidney Dis. 2005; 46: 642-649.
15. Herrmann C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats H, Ruger U. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom Med. 1998; 60: 570-577.
16. Honda H, Quereshi A, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lidhom B. Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006; 47: 139-148.
17. Jofre R, Rodriguez-Benitez O, Lopez-Gomez J, Perez Garcia R. Inflammation syndrome in patients on hemodyalisis. J Am Soc Nephrol. 2006; 17 (Suppl 3): S427-S280.
18. Kalantar-Zadeh K, Block G, Humphreys H, Kopple D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63: 793-808.
19. Kalender B, Ozdemir A, Koroglu G. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract. 2006; 102: c115-c121.
20. Kalender B, Dervisoglu E, Sengul E, Ozdemir A, Akhan S, Yalug I, Uzun H. Depression, nutritional status, and serum cytokines in peritoneal dialysis patients: is there relationship? Perit Dial Int. 2007; 27: 593-595.
21. Kalender B, Ozdemir A, Dervisoglu E, Ozdemir O. Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Int J Clin Pract. 2007; 61: 567-576.
22. Kaysen G, Eiserich J. Characteristic and effects of inflammation in end-stage renal disease. Semin Dial. 2003; 16: 438-446.
23. Keshaviah P. Adequacy of peritoneal dialysis. In: Gokal R, Nolph KD (eds). The Textbook of Peritoneal Dialysis (1st ed). Dordrecht: Kluwer Academic Publishers; 1994. p. 419-442.
24. Khan H. Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transplant. 1998; 13 (Suppl 1): 76-79.
25. Kiecolt-Glaser J, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res. 2002; 53: 873-876.
26. Kim A, Lee K, Huh W, Kim G, Kim J, Oh Y, Kang A, Moon K, Kim W, Kim H. Analysis of depression in continuous ambulatory peritoneal dialysis patients. J Korean Med Sci. 2002; 17: 790-794.
27. Kimmel P, Wihs K, Peterson R. Survival in hemodyalisis patients: the role of depression. J Am Soc Nephrol. 1993; 4: 12-27.
28. Kimmel P, Peterson R, Weihs K, Simmens S, Aleynne S, Cruz I, Veis S. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998; 54: 245-254.
29. Kimmel P, Peterson R, Weihs K, Simmens S, Alleyne S, Cruz I, Weihs K. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000; 67: 2093-2098.
30. Kimmel P, Cukor D, Cohen S, Peterson R. Depression in end-stage renal disease patients: a critical review. Adv Chonr Kidney Dis. 2007; 14: 328-334.
31. Koo R, Yoon W, Kim G, Lee K, Oh H, Kim H, Kim J, Chea W, Noh W, Lee K, Son G. Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 2003; 5: 1037-1042.
32. Lopes A, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port K. Dialysis Outcomes and Practice Patterns Study (DOPPS). Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002; 62: 199-207.
33. Micozkadiouglu H, Micozkadiouglu I., Zumrutdal A, Erdem A, Ozdemir F, Sezer S, Haberal M. Relationship between depressive affect and malnutrition-inflammation syndrome in hemodialysis patients. Nephrology. 2006; 11: 502-505.
34. Miskulin C, Athienites V, Yan G, Martin A, Ornt B, Kusek W, Meyer KB, Levey S for the Hemodilysis (HEMO) Study Group. Comorbidity assessment using the Index of Coexistent Disease in a multicenter clinical trial. Kidney Int. 2001; 60: 1498-1510.
35. Neves P, Morgado E, Faisca M, Carrasqueira H, Baptista A, Silva A. Nutritional and inflammatory status influence darbepoietin dose in pre-dialysis elderly patients. Int Urol Nephrol. 2006; 38: 811-813.
36. Nordfors L, Stenvinkel P, Marchlewska A, Weiss R, Heimbürger O, Bergström J, Lindholm B, Schalling M. Molecular genetics in renal medicine: what can we hope to achieve? Nephrol Dial Transplant. 2002; 17 (Suppl 3): 5-11.
37. Olley B, Seedat S, Nei D, Stein D. Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa. AIDS Patient Care STDS. 2004; 18: 481-487.
38. Pattern S. Long-term medical condition and major depression in Canadian population. Can J Psychiatry. 1999; 44: 151-157.
39. Pescoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inlammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant. 2002; 17 (Suppl 11): 28-31.
40. Pisoni R, Brag-Gresham J, Young E, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK. Anemia management and outcomes from 12 countries in dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004; 44: 94-111.
41. Schrader G, Choek F, Hordacre A, Guiver N. Predictors of depression three months after cardiac hospitalization. Psychosom Med. 2004; 66: 514-520.
42. Simic-Ogrizovic S, Stosovic M, Novakovic I, Pejanovic S, Jemcov T, Radovic M, Djukanovic LJ. Fuzzy role of hyperhomocysteinemia in hemodialysis patients'mortality. Biomed Pharmacother. 2006; 60: 200-207.
43. Stenvikel P, Heimburger O, Lindholm B, Kaysen G, Bergstrom J. Are there two types ofmalnutrition in chronic renal failure? Evidence for relationships between malnutrtion, inflammation and atherosclerosis (MIA syndrom). Nephrol Dial Transplant. 2000; 15: 953-960.
44. Stenvikel P. Inflammation in end-stage renal disease failure: could it be treated? Nephrol Dial Transplant. 2002; 17 (Suppl 8): 33-38.
45. Taskapan H, Ates F, Kaya B, Kaya M, Emul M, Taskapan C, Sahin I. CRP and depression in patients on chronic dialysis. Clin Nephrol. 2003; 60: 443-444.
46. Tiemeir H, Hofman A, van Tuijl H, Kilian A, Meijer J, Breteler M. Inflammatory proteins and depression in the elderly. Epidemiology. 2003; 14: 103-107.
47. Tuglu C, Kara H, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-α levels and treatment response in major depressive disorder. Psychopharmacology. 2003; 170: 429-433.
48. Wang A, Wang M, Woo J, Lam C, Lui S, Li P, Sanderson J. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol. 2004; 15: 2186-2194.
49. Watnick S, Wang P, Demadura T et al. Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis. 2005; 46: 919-924.
50. Yimiya M, Pollak Y, Morag R, Reichenberg A, Barak O, Avtsur R, Shavit Y, Ovadia H, Weidenfeld J, Morag A, Newman M, Pollmacher T. Illness, cytokines, and depression. Ann NY Acad Sci. 2000; 917: 478-487.